PRIA Logo™
119-hr-10649119th CongressWALLET

Safe Disposal of Opioids Act of 2026

Sponsored By: Representative Bonamici, Suzanne [D-OR-1]

Introduced

Summary

Expands safe disposal of unwanted prescription opioids funded by a fee on opioid sales. The bill would create grants for disposal sites and set rules so some patients do not pay the fee.

Show full summary
  • Patients and families: Patients prescribed opioids for cancer care or in hospice, and their estates or medical proxies, would not pay any amount attributable to the fee when buying those drugs.
  • Community disposal sites: Grants would fund establishment and maintenance of medication disposal sites for unwanted prescriptions. No more than 10 percent of annual grant awards may go to law enforcement or to manufacturers and distributors.
  • Manufacturers and federal funding: Manufacturers, producers, or importers would pay a fee of 1 cent per 100 milligrams on active opioids. Annual appropriations to run the grant program could not exceed the total fees collected.

*This bill would tie program funding to fee collections, making the grant program self-financing rather than adding net new federal spending.*

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 1 benefits, 0 costs, 1 mixed.

New opioid fee funds disposal sites

If enacted, manufacturers, producers, and importers would pay a fee of 1 cent for each 100 milligrams of an active opioid they sell. The fee would not apply to drugs used only for medically assisted opioid addiction treatment. For combination drugs, the fee would apply only to the opioid portion. The Attorney General would award grants to covered entities to set up or maintain disposal sites for unwanted prescription medications. No more than 10 percent of total annual grant awards could go to state, local, or tribal law enforcement agencies, manufacturers, distributors, or reverse distributors. Starting in fiscal year 2027, annual appropriations to run the grant program could be authorized up to the total fees collected that year.

No opioid fee for cancer and hospice

If enacted, the Secretary of Health and Human Services would set up a way to remove the bill’s fee from the price when eligible patients buy active opioids. The fee amount is 1 cent per 100 milligrams of active opioid, and the discount would cover that fee at the time of payment. Eligible patients would include those prescribed an active opioid for cancer-related pain or cancer treatment, and those in hospice care. After a qualifying patient dies or becomes incapacitated, a family member, medical proxy, similar representative, or the patient’s estate could qualify for the discount.

Sponsors & CoSponsors

Sponsor

Bonamici, Suzanne [D-OR-1]

OR • D

Cosponsors

  • Rep. Moore, Riley M. [R-WV-2]

    WV • R

    Sponsored 10/1/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation